Published in Radiology on February 01, 2002
The ACR BI-RADS experience: learning from history. J Am Coll Radiol (2009) 2.68
Comparing screening mammography for early breast cancer detection in Vermont and Norway. J Natl Cancer Inst (2008) 2.01
Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance? AJR Am J Roentgenol (2010) 1.49
Applications and literature review of the BI-RADS classification. Eur Radiol (2005) 1.36
Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control (2015) 1.16
The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions. Manuf Serv Oper Manag (2012) 1.08
New developments in observer performance methodology in medical imaging. Semin Nucl Med (2011) 1.02
Sensitivity and specificity of mammographic screening as practised in Vermont and Norway. Br J Radiol (2012) 0.95
Accuracy of short-interval follow-up mammograms by patient and radiologist characteristics. AJR Am J Roentgenol (2008) 0.95
Diagnostic mammography: identifying minimally acceptable interpretive performance criteria. Radiology (2013) 0.89
BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit. Eur Radiol (2011) 0.84
Performance of diagnostic mammography differs in the United States and Denmark. Int J Cancer (2010) 0.83
Association of symptoms and breast cancer in population-based mammography screening in Finland. Int J Cancer (2014) 0.82
Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy. J Am Coll Radiol (2016) 0.81
Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol (2014) 0.81
Optimal Policies for Reducing Unnecessary Follow-up Mammography Exams in Breast Cancer Diagnosis. Decis Anal (2013) 0.80
Breast imaging reports for malignant lesions: are we maintaining recommended BI-RADS(®) lexicon standards? Cancer Manag Res (2012) 0.78
A history of breast cancer and older age allow risk stratification of mammographic BI-RADS 3 ratings in the diagnostic setting. Clin Imaging (2015) 0.78
Observer Variability of the Breast Imaging Reporting and Data System (BI-RADS) Lexicon for Mammography. Breast Care (Basel) (2010) 0.77
Volumetric breast ultrasound as a screening modality in mammographically dense breasts. ISRN Radiol (2012) 0.75
Assessing Inaccuracies in Automated Information Extraction of Breast Imaging Findings. J Digit Imaging (2016) 0.75
Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice. AJR Am J Roentgenol (2016) 0.75
Efficacy of Sonoelastography in Distinguishing Benign from Malignant Breast Masses. J Breast Health (2013) (2016) 0.75
Clinico-pathological Correlation of Thyroid Nodule Ultrasound and Cytology Using the TIRADS and Bethesda Classifications. World J Surg (2017) 0.75
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol (2009) 9.39
Influence of computer-aided detection on performance of screening mammography. N Engl J Med (2007) 8.58
Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol (2003) 8.25
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am J Epidemiol (2003) 7.68
Survival model predictive accuracy and ROC curves. Biometrics (2005) 7.26
The case for early detection. Nat Rev Cancer (2003) 6.96
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol (2007) 6.11
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature (2008) 5.98
Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain. Arch Intern Med (2009) 4.96
Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr (2005) 4.92
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer (2007) 4.76
Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol (2007) 4.59
Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA (2003) 4.54
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med (2015) 4.53
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Antibiotic use in relation to the risk of breast cancer. JAMA (2004) 4.28
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res (2003) 4.13
Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst (2004) 4.07
Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med (2006) 3.95
Combination anastrozole and fulvestrant in metastatic breast cancer. N Engl J Med (2012) 3.86
Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst (2004) 3.86
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75
Effectiveness of computer-aided detection in community mammography practice. J Natl Cancer Inst (2011) 3.62
Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst (2009) 3.48
Association of volume and volume-independent factors with accuracy in screening mammogram interpretation. J Natl Cancer Inst (2003) 3.41
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25
Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst (2005) 3.06
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance. Cancer Res (2008) 3.05
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Reported drop in mammography : is this cause for concern? Cancer (2007) 2.91
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88
Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol (2013) 2.87
Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst (2005) 2.86
Association between mammography timing and measures of screening performance in the United States. Radiology (2005) 2.85
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85
Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst (2004) 2.84
When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology (2009) 2.78
Physical activity recommendations and decreased risk of mortality. Arch Intern Med (2007) 2.76
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials. J Clin Oncol (2011) 2.73
The difference engine: a model of diversity in speeded cognition. Psychon Bull Rev (2003) 2.73
Physician predictors of mammographic accuracy. J Natl Cancer Inst (2005) 2.72
A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev (2003) 2.71
The ACR BI-RADS experience: learning from history. J Am Coll Radiol (2009) 2.68
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst (2003) 2.65